Redeye: Imint - Evaluating new areas

Imint reported net sales of SEK 5.3m in Q3, which thereby was in line with our estimates. Costs were lower than expected, which led to EBIT of SEK -1.4m (vs expected SEK -2.3m).

Read more and download the Research Update:

Start following companies at Redeye to receive the latest equity research within Life Science and Technology.

This is a press release from Redeye – Research Powered Investment Banking.


We’re all about video enhancement

Book a Demo